691 related articles for article (PubMed ID: 16474405)
21. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies.
Komatsuzaki S; Aoki Y; Niihori T; Okamoto N; Hennekam RC; Hopman S; Ohashi H; Mizuno S; Watanabe Y; Kamasaki H; Kondo I; Moriyama N; Kurosawa K; Kawame H; Okuyama R; Imaizumi M; Rikiishi T; Tsuchiya S; Kure S; Matsubara Y
J Hum Genet; 2010 Dec; 55(12):801-9. PubMed ID: 20882035
[TBL] [Abstract][Full Text] [Related]
23. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
[TBL] [Abstract][Full Text] [Related]
24. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism.
Jafarov T; Ferimazova N; Reichenberger E
Clin Genet; 2005 Aug; 68(2):190-1. PubMed ID: 15996221
[No Abstract] [Full Text] [Related]
25. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
[TBL] [Abstract][Full Text] [Related]
26. Acute lymphoblastic leukaemia in Noonan syndrome.
Roti G; La Starza R; Ballanti S; Crescenzi B; Romoli S; Foá R; Tartaglia M; Aversa F; Fabrizio Martelli M; Mecucci C
Br J Haematol; 2006 May; 133(4):448-50. PubMed ID: 16643459
[No Abstract] [Full Text] [Related]
27. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular characterization of 40 patients with Noonan syndrome.
Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC
Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287
[TBL] [Abstract][Full Text] [Related]
29. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V
Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949
[TBL] [Abstract][Full Text] [Related]
30. Does the rare A172G mutation of PTPN11 gene convey a mild Noonan syndrome phenotype?
Kitsiou-Tzeli S; Papadopoulou A; Kanaka-Gantenbein C; Fretzayas A; Daskalopoulos D; Kanavakis E; Nicolaidou P
Horm Res; 2006; 66(3):124-31. PubMed ID: 16804314
[TBL] [Abstract][Full Text] [Related]
31. Pilocytic astrocytoma in a child with Noonan syndrome.
Schuettpelz LG; McDonald S; Whitesell K; Desruisseau DM; Grange DK; Gurnett CA; Wilson DB
Pediatr Blood Cancer; 2009 Dec; 53(6):1147-9. PubMed ID: 19621452
[TBL] [Abstract][Full Text] [Related]
32. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
33. Severe aortic valvar stenosis in familial Noonan syndrome with mutation of the PTPN11 gene.
Abadir S; Edouard T; Julia S
Cardiol Young; 2007 Feb; 17(1):95-7. PubMed ID: 17184563
[TBL] [Abstract][Full Text] [Related]
34. Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation.
Chantrain CF; Jijon P; De Raedt T; Vermylen C; Poirel HA; Legius E; Brichard B
Pediatr Blood Cancer; 2007 Jan; 48(1):101-4. PubMed ID: 16078230
[TBL] [Abstract][Full Text] [Related]
35. Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation.
Yoshida R; Ogata T; Masawa N; Nagai T
Pediatr Blood Cancer; 2008 Jun; 50(6):1274-6. PubMed ID: 18253957
[TBL] [Abstract][Full Text] [Related]
36. Genetics and variation in phenotype in Noonan syndrome.
Jongmans M; Otten B; Noordam K; van der Burgt I
Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
[TBL] [Abstract][Full Text] [Related]
37. Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
Lee WH; Raas-Rotschild A; Miteva MA; Bolasco G; Rein A; Gillis D; Vidaud D; Vidaud M; Villoutreix BO; Parfait B
Proteins; 2005 Jan; 58(1):7-13. PubMed ID: 15521065
[TBL] [Abstract][Full Text] [Related]
38. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation.
Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T
Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108
[No Abstract] [Full Text] [Related]
39. Novel mitochondrial DNA mutations implicated in Noonan syndrome.
Dhandapany PS; Sadayappan S; Vanniarajan A; Karthikeyan B; Nagaraj C; Gowrishankar K; Selvam GS; Singh L; Thangaraj K
Int J Cardiol; 2007 Aug; 120(2):284-5. PubMed ID: 17092585
[TBL] [Abstract][Full Text] [Related]
40. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome.
Karow A; Steinemann D; Göhring G; Hasle H; Greiner J; Harila-Saari A; Flotho C; Zenker M; Schlegelberger B; Niemeyer CM; Kratz CP
Leukemia; 2007 Jun; 21(6):1303-5. PubMed ID: 17361219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
